MAI Capital Management

Position in NBIX — Neurocrine Biosciences Inc

CIK 1040197 INDEPENDENCE, OH

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,364,498

+$805,657 QoQ

Shares Held

8,096

+90.9% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#362

of 774 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MAI Capital Management holds $5,871,377 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (23.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	24,462	$1,757,838
2	NBIX	Neurocrine Biosciences Inc This page	8,096	$1,364,498
3	UTHR	UNITED THERAPEUTICS Corp	1,934	$1,047,898
4	VTRS	Viatris Inc	32,111	$509,922
5	TEVA	Teva Pharmaceutical Industries Ltd	8,901	$301,565
6	HLN	Haleon plc	29,413	$274,422
7	ANIP	Ani Pharmaceuticals Inc	2,683	$222,098
8	TAK	Takeda Pharmaceutical Co Ltd	10,292	$164,979

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,364,498	8,096	+90.9%	Shares	Sole	2026-08-14
2026-03-31	$558,841	4,242	+891.1%	Shares	Sole	2026-05-15
2025-12-31	$60,703	428	+237.0%	Shares	Sole	2026-02-13
2025-09-30	$17,828	127	-61.3%	Shares	Sole	2025-11-10
2025-06-30	$41,226	328	+101.2%	Shares	Sole	2025-08-12
2025-03-31	$18,027	163	-41.8%	Shares	Sole	2025-05-15
2024-12-31	$38,220	280	-95.6%	Shares	Sole	2025-02-14
2022-06-30	$625,041	6,412	0.0%	Shares	Sole	2022-07-19
2022-03-31	$601,125	6,412	+13.1%	Shares	Sole	2022-05-10
2021-12-31	$482,658	5,667	+6.7%	Shares	Sole	2022-02-11
2021-09-30	$509,473	5,312	+3.3%	Shares	Sole	2021-11-12
2021-06-30	$500,322	5,141	-0.0%	Shares	Sole	2021-07-19
2021-03-31	$500,156	5,143	+17.4%	Shares	Sole	2021-05-10
2020-12-31	$419,918	4,381	-19.7%	Shares	Sole	2021-02-16
2020-09-30	$524,648	5,456	—	Shares	Sole	2020-10-26
No filing history on record for this holder in this stock.